Cummings Olivia W, Meléndez-Montañez Jesús M, Naraine Leah, Yavuz Saricay Leyla, El Helwe Hani, Solá-Del Valle David
Warren Alpert Medical School of Brown University, Providence, RI, USA.
Ponce School of Medicine, Ponce Health Sciences University, Ponce, PR, USA.
Am J Ophthalmol Case Rep. 2024 May 3;35:102069. doi: 10.1016/j.ajoc.2024.102069. eCollection 2024 Sep.
This case report highlights a possible association between netarsudil use and crystalline keratopathy.
Presented here is the case of a 72-year-old woman with primary open-angle glaucoma (POAG) who developed corneal crystalline keratopathy after taking netarsudil for 24 months. The patient's medical history was significant for dry eye syndrome, bilateral ptosis with surgical repair, and atopy (including asthma and various ocular and systemic allergies). The patient had previously undergone surgical repair for bilateral ptosis as well. During the interval between two routine visits, this patient experienced worsening vision with associated eye irritation. Further examination revealed crystal deposits on the anterior corneal surface in the left eye, the only eye undergoing netarsudil treatment.
Long-term netarsudil use may be associated with crystalline keratopathy in the anterior stroma, with the potential to cause sight-threatening vision loss if located in the visual axis.
本病例报告强调了奈他地尔使用与结晶性角膜病变之间可能存在的关联。
本文介绍了一名72岁原发性开角型青光眼(POAG)女性患者的病例,该患者在服用奈他地尔24个月后出现角膜结晶性角膜病变。患者的病史包括干眼症、双侧上睑下垂并接受手术修复以及特应性体质(包括哮喘和各种眼部及全身过敏)。该患者此前也接受过双侧上睑下垂的手术修复。在两次常规就诊的间隔期间,该患者出现视力恶化并伴有眼部刺激症状。进一步检查发现,仅接受奈他地尔治疗的左眼角膜前表面有晶体沉积。
长期使用奈他地尔可能与前基质的结晶性角膜病变有关,如果位于视轴上,有可能导致威胁视力的视力丧失。